title: Response by Link et al to Letter Regarding Article, "Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation".
authors.affiliation: From Cardiac Electrophysiology, UT Southwestern Medical Center, Dallas, TX (M.S.M.); Liryc Institute (Electrophysiology and Heart Modeling Institute), Hopital Cardiologique du Haut-Leveque, CHU Bordeaux, Universite de Bordeaux, Bordeaux, France (M.H.); and Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin (A.N.).
authors.forename: Mark S
authors.initials: MS
authors.lastname: Link
authors.affiliation: From Cardiac Electrophysiology, UT Southwestern Medical Center, Dallas, TX (M.S.M.); Liryc Institute (Electrophysiology and Heart Modeling Institute), Hopital Cardiologique du Haut-Leveque, CHU Bordeaux, Universite de Bordeaux, Bordeaux, France (M.H.); and Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin (A.N.).
authors.forename: Michel
authors.initials: M
authors.lastname: Haïssaguerre
authors.affiliation: From Cardiac Electrophysiology, UT Southwestern Medical Center, Dallas, TX (M.S.M.); Liryc Institute (Electrophysiology and Heart Modeling Institute), Hopital Cardiologique du Haut-Leveque, CHU Bordeaux, Universite de Bordeaux, Bordeaux, France (M.H.); and Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin (A.N.).
authors.forename: Andrea
authors.initials: A
authors.lastname: Natale
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D017115:Catheter Ablation; D006801:Humans; D018579:Patient Selection; D016896:Treatment Outcome; D014859:Warfarin
chemical_list: D000925:Anticoagulants; D014859:Warfarin